CN1077641A - The Chinese patent medicine Naozhenning of treatment combined external head injuries - Google Patents

The Chinese patent medicine Naozhenning of treatment combined external head injuries Download PDF

Info

Publication number
CN1077641A
CN1077641A CN93100741A CN93100741A CN1077641A CN 1077641 A CN1077641 A CN 1077641A CN 93100741 A CN93100741 A CN 93100741A CN 93100741 A CN93100741 A CN 93100741A CN 1077641 A CN1077641 A CN 1077641A
Authority
CN
China
Prior art keywords
medicine
naozhenning
chinese patent
chinese
radix
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN93100741A
Other languages
Chinese (zh)
Other versions
CN1047524C (en
Inventor
武国宪
田成兴
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SHANXI ANTE BIOLOGICAL PHARMACEUTICAL CO Ltd
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CN1077641A publication Critical patent/CN1077641A/en
Application granted granted Critical
Publication of CN1047524C publication Critical patent/CN1047524C/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

A kind of Chinese patent medicine Naozhenning for the treatment of combined external head injuries, Chinese and western medicine does not all have the desirable medicine of special for treating combined external head injuries at present, the present invention has broken the Therapeutic Method of traditional traditional Chinese medical science to cerebral trauma, based on promoting blood circulation to remove obstruction in the collateral, invigorating the spleen to clear away damp pathogen, calm the nerves, Fructus Alpiniae Oxyphyllae is auxilliary, select the Radix Rehmanniae, Radix Angelicae Sinensis, Rhizoma Chuanxiong, Pheretima, Cortex Moutan, Radix Salviae Miltiorrhizae, Poria, Pericarpium Citri Reticulatae, Caulis Bambusae In Taenia, Semen Ziziphi Spinosae (parched), Semen Platycladi ten Chinese medicine is simply formed, obtained beyond thought curative effect, this medical instrument has hypnosis, calm, effect is told in analgesia and town, do not have any toxicity and side effect, clinical effective rate reaches more than 90%.

Description

The Chinese patent medicine Naozhenning of treatment combined external head injuries
The present invention is a kind of Chinese patent medicine for the treatment of postcerebrotraumatic syndrome.
Postcerebrotraumatic syndrome is a kind of commonly encountered diseases, symptoms such as most of patients has headache, dizziness, feels sick, vomiting, insomnia, but still there is not comparatively ideal medicine to treating this disease both at home and abroad at present, doctor trained in Western medicine does not have the medicine of special for treating cerebral trauma, can only symptomatic treatment (seeing high medical college teaching material " surgery " third edition that the People's Health Publisher publishes), then with the principle methods treatments of adopting warm medicine blood circulation promoting and blood stasis dispelling of " cold then blood clotting ", the curative effect majority is also unsatisfactory more for the traditional Chinese medical science.
The present invention aims to provide different special for treating postcerebrotraumatic syndrome of a kind of and traditional Chinese traditional treatment method and the high pure Chinese patent medicine preparation of curative effect.
For reaching above-mentioned purpose, every dose in preparation of the present invention is made up of following 11 flavor Chinese medicine ingredients:
Radix Rehmanniae 7-12g Radix Angelicae Sinensis 7-12g Rhizoma Chuanxiong 5-10g Pheretima 5-10g
Cortex Moutan 6-11g Radix Salviae Miltiorrhizae 15-20g Poria 10-15g Pericarpium Citri Reticulatae 10-15g
Caulis Bambusae In Taenia 6-11g Semen Ziziphi Spinosae (parched) 6-11g Semen Platycladi 6-11g
The treatment mechanism of above-mentioned prescription is: with promoting blood circulation to remove obstruction in the collateral treatment headache, dizziness, with invigorating the spleen to clear away damp pathogen treatment nausea and vomiting, with the benefiting intelligence and curing insomnia, forgetful of calming the nerves, its resultant effect helps the recovery of cerebral trauma.
For postcerebrotraumatic syndrome, because Traditional Chinese medical theory is thought " cold then blood clotting ", so all adopt the warm nature blood circulation promoting medicine to carry out activating blood and resolving stasis and treating, this prescription has then been broken this traditional Therapeutic Method, adopt " promoting blood circulation to remove obstruction in the collateral " to be aided with invigorating the spleen to clear away damp pathogen again, the method of Fructus Alpiniae Oxyphyllae of calming the nerves is executed and is controlled, and has obtained beyond thought therapeutic effect.
According to 484 routine clinical cases are observed, this medicine effective percentage reaches more than 90%, wherein 184 routine clinicaling curative effect contrast observation's materials to Shanxi Medical College's first Affiliated Hospital's department of neurology and People's Hospital of Shanxi Prov.'s department of neurology carry out statistical procedures, conclusion is: this medicine is extremely remarkable with the cure rate difference of Western medicine, P<0.01, effective percentage (comprising cure rate and obvious effective rate) difference is extremely remarkable, P<0.01.
According to pharmacological research, conclusion is: this medicine has hypnosis, calmness, analgesia and town to tell effect.
According to acute toxicity test, conclusion is: its mouse oral LD 50Greater than 25g/kg, illustrate that this medicine is extremely low to white mice toxicity.
A large amount of these medicines of clinical trial certificate are in the reparation that promotes the brain injury tissue, correct the not normal and controlling symptoms aspect of vegetative nerve positive effect is arranged, it is unified normally really to have reached elimination symptom and pathology functional rehabilitation, therefore obtained satisfied curative effect, the rare effective Chinese medicine of treatment postcerebrotraumatic syndrome both at home and abroad of being known as at present.
Embodiment 1, every dose prescription:
Radix Rehmanniae 7g Radix Angelicae Sinensis 8g Rhizoma Chuanxiong 5g Pheretima 6g Cortex Moutan 5g
Radix Salviae Miltiorrhizae 16g Poria 12g Pericarpium Citri Reticulatae 11g Caulis Bambusae In Taenia 6g Semen Ziziphi Spinosae (parched) 11g
Semen Platycladi 6g
Embodiment 2, every dose prescription:
Radix Rehmanniae 10g Radix Angelicae Sinensis 12g Rhizoma Chuanxiong 6g Pheretima 5g Cortex Moutan 6g
Radix Salviae Miltiorrhizae 19g Poria 15g Pericarpium Citri Reticulatae 15g Caulis Bambusae In Taenia 9g Semen Ziziphi Spinosae (parched) 9g
Semen Platycladi 8g
Embodiment 3, every dose prescription:
Radix Rehmanniae 12g Radix Angelicae Sinensis 10g Rhizoma Chuanxiong 9g Pheretima 9g Cortex Moutan 9g
Radix Salviae Miltiorrhizae 18g Poria 10g Pericarpium Citri Reticulatae 12g Caulis Bambusae In Taenia 10g Semen Ziziphi Spinosae (parched) 8g
Semen Platycladi 9g
Embodiment 4, every dose prescription:
Radix Rehmanniae 8g Radix Angelicae Sinensis 9g Rhizoma Chuanxiong 10g Pheretima 10g Cortex Moutan 10g
Radix Salviae Miltiorrhizae 20g Poria 13g Pericarpium Citri Reticulatae 14g Caulis Bambusae In Taenia 11g Semen Ziziphi Spinosae (parched) 6g
Semen Platycladi 10g
Embodiment 5, every dose prescription:
Radix Rehmanniae 9g Radix Angelicae Sinensis 7g Rhizoma Chuanxiong 8g Pheretima 8g Cortex Moutan 11g
Radix Salviae Miltiorrhizae 15g Poria 11g Pericarpium Citri Reticulatae 10g Caulis Bambusae In Taenia 8g Semen Ziziphi Spinosae (parched) 10g
Semen Platycladi 11g
Embodiment 6, take by weighing medicine by aforementioned formula, decoct with water concentratedly, make the Naozhenning decoct.
Embodiment 7,
(1): take by weighing medicine by aforementioned prescription composition.
(2): with being ground into coarse powder after the Radix Rehmanniae, the Poria oven dry, with Cortex Moutan, Radix Angelicae Sinensis, Pericarpium Citri Reticulatae, Semen Ziziphi Spinosae (parched), the direct crushing screening of Semen Platycladi.
(3): after Cortex Moutan, Radix Angelicae Sinensis, Pericarpium Citri Reticulatae, Rhizoma Chuanxiong be soaked in water 24 hours, carry out steam distillation, distillate freezing 24 hours is told volatile oil, medicinal residues behind the steam distillation, reuse decocting in water are carried three times, each one hour, merge medicinal liquid, filter, filtrate is condensed into paste, and is standby.
(4): with the Radix Rehmanniae, Radix Salviae Miltiorrhizae, Poria, Caulis Bambusae In Taenia (broken section), Semen Ziziphi Spinosae (parched), Pheretima, Semen Platycladi, carry three times with decocting in water respectively, each one hour, filter, filtrate merging be condensed into the thick paste shape, standby.
(5): the thick paste of (3), (4) step preparation with an amount of dextrin mixing, is added an amount of Icing Sugar, mixed pelletization secondary, 50 ℃ of oven dry of granule, granulate.
(6): with the granule behind the granulate, add volatile oil (earlier with the fine powder mixing behind the granulate), the fine powder mix homogeneously of described liquid medicine steam distillation gained of (3) step, place after 24 hours, be distributed into every bag of 15g.
Make the Naozhenning electuary with said method.
Embodiment 8,
(1): take by weighing medicine by aforementioned prescription composition.
(2): with being ground into coarse powder after the Radix Rehmanniae, the Poria oven dry, with Cortex Moutan, Radix Angelicae Sinensis, Pericarpium Citri Reticulatae, Semen Ziziphi Spinosae (parched), the direct crushing screening of Semen Platycladi.
(3): after Cortex Moutan, Radix Angelicae Sinensis, Pericarpium Citri Reticulatae, Rhizoma Chuanxiong be soaked in water 24 hours, carry out steam distillation, distillate freezing 24 hours is told volatile oil.Medicinal residues behind the steam distillation, reuse decocting in water are carried three times, and each one hour, merge medicinal liquid, filtration, filtrate and be condensed into paste, add appropriate amount of starch, dry, pulverized 80 mesh sieves, standby.
(4): with the Radix Rehmanniae, Radix Salviae Miltiorrhizae, Poria, Caulis Bambusae In Taenia (broken section), Semen Ziziphi Spinosae (parched), Pheretima, Semen Platycladi are carried three times with decocting in water respectively, and each one hour, 80 mesh sieves are crossed in dry, pulverizing, and were standby.
(5): two parts powder of above-mentioned (3), (4) described preparation is sieved, mix secondary.
(6): aforementioned (3) step gained volatile oil is added in the powder of mixing, mixed the back thoroughly airtight 24 hours, be sub-packed in the capsule then.
Make the Naozhenning capsule with said method.
Embodiment 9,
(1): take by weighing medicine by aforementioned prescription composition.
(2): with being ground into coarse powder after the Radix Rehmanniae, the Poria oven dry, with Cortex Moutan, Radix Angelicae Sinensis, Pericarpium Citri Reticulatae, Semen Ziziphi Spinosae (parched), the direct crushing screening of Semen Platycladi.
(3): after Cortex Moutan, Radix Angelicae Sinensis, Pericarpium Citri Reticulatae, Rhizoma Chuanxiong be soaked in water 24 hours, carry out steam distillation, distillate freezing 24 hours is told volatile oil.Medicinal residues behind the steam distillation, reuse decocting in water are carried three times, and each one hour, merge medicinal liquid, to filter, filtrate is condensed into paste, adds appropriate amount of starch, and drying was pulverized 80 mesh sieves, and was standby.
(4): with the Radix Rehmanniae, Radix Salviae Miltiorrhizae, Poria, Caulis Bambusae In Taenia (broken section), Semen Ziziphi Spinosae (parched), Pheretima, Semen Platycladi, carry three times with decocting in water respectively, each one hour, filter, filtrate merging be condensed into the thick paste shape, add appropriate amount of starch, dry, mistake 80 mesh sieves, standby.
(5): two parts raw material of (3), (4) described preparation is added appropriate amount of auxiliary materials, mixing, granulation, dry granulate, standby.
(6): above-mentioned (3) step gained volatile oil is added in the granule of mixing, mix back sealing 24 hours thoroughly, tabletting, sugar coating.
Make the Naozhenning tablet with said method.

Claims (6)

1, a kind of Chinese patent medicine Naozhenning for the treatment of combined external head injuries is characterized in that: this medicine by the Radix Rehmanniae, Radix Angelicae Sinensis, Rhizoma Chuanxiong, Pheretima, Cortex Moutan, Radix Salviae Miltiorrhizae, Poria, Pericarpium Citri Reticulatae, Caulis Bambusae In Taenia, Semen Ziziphi Spinosae (parched), Semen Platycladi ten simply Chinese medicine form.
2, Chinese patent medicine Naozhenning as claimed in claim 1 is characterized in that: described ten simply every dose of composition proportion of Chinese medicine be:
Radix Rehmanniae 7-12g Radix Angelicae Sinensis 7-12g Rhizoma Chuanxiong 5-10g
Pheretima 5-10g Cortex Moutan 6-11g Radix Salviae Miltiorrhizae 15-20g
Poria 10-15g Pericarpium Citri Reticulatae 10-15g Caulis Bambusae In Taenia 6-11g
Semen Ziziphi Spinosae (parched) 6-11g Semen Platycladi 6-11g
3, Chinese patent medicine Naozhenning as claimed in claim 1 or 2 is characterized in that: this medicine is the decoct dosage form.
4, Chinese patent medicine Naozhenning as claimed in claim 1 or 2 is characterized in that: this medicine is the electuary dosage form.
5, Chinese patent medicine Naozhenning as claimed in claim 1 or 2 is characterized in that: this medicine is the capsule dosage form.
6, Chinese patent medicine Naozhenning as claimed in claim 1 or 2 is characterized in that: this medicine is a Tabules.
CN93100741A 1992-10-09 1993-01-01 Chinese patent medicine, "Naozhenning" for treatment of brain trauma syndrome Expired - Lifetime CN1047524C (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN92111513 1992-10-09
CH92111513.X 1992-10-09

Publications (2)

Publication Number Publication Date
CN1077641A true CN1077641A (en) 1993-10-27
CN1047524C CN1047524C (en) 1999-12-22

Family

ID=4945382

Family Applications (1)

Application Number Title Priority Date Filing Date
CN93100741A Expired - Lifetime CN1047524C (en) 1992-10-09 1993-01-01 Chinese patent medicine, "Naozhenning" for treatment of brain trauma syndrome

Country Status (1)

Country Link
CN (1) CN1047524C (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103386080A (en) * 2013-07-08 2013-11-13 张秀菊 Medicine composite for curing combined external head injuries in clinical nursing
CN105194311A (en) * 2015-10-21 2015-12-30 孔德华 Traditional Chinese medicine preparation for rehabilitation of brain trauma and preparation method thereof
CN106822611A (en) * 2016-12-28 2017-06-13 华北理工大学 A kind of Chinese medicine composition for nursing postcerebrotraumatic syndrome and preparation method thereof
CN107179380A (en) * 2017-06-21 2017-09-19 山西振东安特生物制药有限公司 Naozhenning TLC Identification
CN107184848A (en) * 2017-06-19 2017-09-22 山西振东安特生物制药有限公司 The new pharmaceutical use of Naozhenning preparation

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103386080A (en) * 2013-07-08 2013-11-13 张秀菊 Medicine composite for curing combined external head injuries in clinical nursing
CN103386080B (en) * 2013-07-08 2014-10-22 张秀菊 Medicine composite for curing combined external head injuries in clinical nursing
CN105194311A (en) * 2015-10-21 2015-12-30 孔德华 Traditional Chinese medicine preparation for rehabilitation of brain trauma and preparation method thereof
CN106822611A (en) * 2016-12-28 2017-06-13 华北理工大学 A kind of Chinese medicine composition for nursing postcerebrotraumatic syndrome and preparation method thereof
CN107184848A (en) * 2017-06-19 2017-09-22 山西振东安特生物制药有限公司 The new pharmaceutical use of Naozhenning preparation
WO2018233471A1 (en) * 2017-06-19 2018-12-27 山西振东安特生物制药有限公司 New pharmaceutical use of naozhenning preparation
CN107184848B (en) * 2017-06-19 2021-11-19 山西振东安特生物制药有限公司 New pharmaceutical use of Naozhenning preparation
CN107179380A (en) * 2017-06-21 2017-09-19 山西振东安特生物制药有限公司 Naozhenning TLC Identification

Also Published As

Publication number Publication date
CN1047524C (en) 1999-12-22

Similar Documents

Publication Publication Date Title
CN1186043C (en) Exterior-applied medicine for treating osteopathy
CN1286474C (en) Medicine for treating bone wound
CN1193775C (en) Rheumatoid disease treating capsule
CN102614305A (en) Medicament for treating allergic purpura
CN101537093A (en) Chinese traditional medicine for preventing and curing osteoporosis and preparation method thereof
CN1686318A (en) Chinese medicinal composition for treating cervical vertebra disease, lumbar vertebra disease and ischialgia
CN1047524C (en) Chinese patent medicine, "Naozhenning" for treatment of brain trauma syndrome
CN1129130A (en) Medicament for treatment of cervical spondylopathy
CN1250264C (en) Capsule for curing hyperplasia of mammary glands and its preparation method
CN1528386A (en) Chinese medicine composition for treating rheumatism, rheumatoid, hyperosteogeny and fracture and preparing method thereof
CN1298362C (en) Compound Chinese medicine prepn for treating pulvic infection and its prepn process
CN101036696A (en) Medicine combination for curing orthopaedics disease and the method for preparing the same
CN101040949A (en) Medicine compound for creating rheumatism and rheumatoid arthritis and the preparing method and apllication
CN1324650A (en) Effective medicine for treating cervical vertebra disease as one kind of intractable disease
CN1083714A (en) A kind of cancer therapy drug of Chinese medicinal components
CN105770251A (en) Tongning capsule for treatment of cervical spondylosis, lumbar diseases and arthritis
CN1276771C (en) Chinese materia medica preparation for treating spasm of eye and facial muscles, and preparing method
CN1092968C (en) Pharmaceuticals for treating outer skin blood vessel diease in cold seasons
CN1112191C (en) Medicine for treating rheumatic arthritis and hyperosteogeny and its preparing process
CN1602905A (en) Externally applied medicine for treating hyperosteogeny and intervertebral disc protrusion and its preparation method
CN1091382C (en) Compound Lingxian headache-treating capsule and its preparation
CN1205989C (en) Medicine composition for treating ischemic necrosis of femur head and preparing process thereof
CN1089862A (en) Anti-inflammatory tablet for treatment of arthritis
CN105687784A (en) Traditional Chinese medicine for oral administration and plaster for treating cervical vertebra, scapulohumeral periarthritis and lumbar disc herniation
CN1129136A (en) A Chinese medicinal composition for treating hyperosteogeny

Legal Events

Date Code Title Description
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C06 Publication
PB01 Publication
C14 Grant of patent or utility model
GR01 Patent grant
ASS Succession or assignment of patent right

Owner name: NONE

Free format text: FORMER OWNER: TIAN CHENGXING

Effective date: 20020708

Owner name: SHANXI ANTE BIOLOGICAL PHARMACEUTICAL CO., LTD.

Free format text: FORMER OWNER: WU GUOBIN

C41 Transfer of patent application or patent right or utility model
TR01 Transfer of patent right

Effective date of registration: 20020708

Address after: No. 87, South inner ring street, Shanxi, Taiyuan

Patentee after: Shanxi Ante Biological Pharmaceutical Co., Ltd.

Address before: Shanxi worker's Medical College of Taiyuan city Shanxi Province

Co-patentee before: Tian Chengxing

Patentee before: Wu Guobin

C17 Cessation of patent right
CX01 Expiry of patent term

Expiration termination date: 20130104

Granted publication date: 19991222